The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression

New York State Psychiatric Institute, New York

Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Berlin

Sheppard Pratt Health System, Baltimore

Mood and Anxiety Disorders Program Emory University School of Medicine, Atlanta

Ray Worthy Psychiatry LLC, New Orleans

UT Center of Excellence on Mood Disorders, University of Texas Health Science Center, Houston

Kadima Neuropsychiatry Institute, La Jolla

Altman Clinical and Translational Research Institute, University of California, San Diego

Stanford Department of Psychiatry, Stanford

Canadian Rapid Treatment Centre of Excellence, Mississauga

Centre for Addiction and Mental Health, Toronto

National Institute of Mental Health Czech Republic, Klecany

Enhed for Psykiatrisk Forskning, Psykiatrien i Aalborg, Aalborg

Tallaght University Hospital, Dublin

Groningen University Medical Centre, Groningen

Leiden University Medical Centre, Leiden

Utrecht University Medical Centre, Utrecht

Unidade de Neuropsiquiatria, Centro Clinico Champalimaud, Lisbon

Hospital de Dia Numancia, Barcelona

Institute Hospital del Mar of Medical Research (IMIM), Barcelona

Clinical Research and Imaging Centre, Bristol

Kings College London, Institute of Psychiatry, Psychology and Neurology, London

Greater Manchester Mental Health Foundation Trust, Manchester

Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne

St. Pancras Clinical Research, London